J U LY 2 0 1 5 O U T P A T I E N TS U R G E R Y. N E T 6 1
ask the questions that can result in
antiemetic interventions, not to mention
the tracking of effectiveness. Health care
is moving steadily toward performance-
based and quality-based efforts. By taking
steps to reduce the incidence of PONV,
anesthesia providers — who have a big
stake in patient satisfaction — will be
there.
OSM
What Health Care
Professionals are saying about
QueaseEASE...
"QueaseEASE
is
the
first
thing
I
reach
for
with
the
start
of
any
PONV."
-
Haley
Arnold,
RN,
BSN,
Clinical
Supervisor
REQUEST A FREE SAMPLE KIT
sample@soothing-scents.com or 1-888-393-7330
AROMATIC INHALER
QueaseEASE was
developed by a CRNA
for PONV. The aromaŸc
inhaler is available in two
formats: the Quick Pack
disposable and the long lasŸng
proprietary
aromaŸc wand.
Dr. Smith (csmith@aayofpa.com) is a nurse anes-
thetist with Anesthesia Associates of York (Pa.)
who practices at Wellspan York Hospital. He con-
ducted his PONV research for his doctor of nursing
practice degree at York College of Pennsylvania.
